The article 🌱 Patch AM: Which Groton restaurants failed recent underage alcohol compliance checks? appeared first on Groton ...

Arrowhead’s RNA drugs could aid with “high-quality” weight loss, according to one analyst. Elsewhere, the PD-1/VEGF field got less crowded and Amgen and Lilly struck startup deals.

Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more ...

Nimbus will apply its computational chemistry and structure-based drug design to a discovery programme in obesity treatment.

Biopharma industry zeal for obesity therapeutics does not appear to be dying down any time soon, with Eli Lilly and Co. entering a $1.3 billion deal with Nimbus Therapeutics LLC for a new small ...

Nimbus will ⁠use its ⁠AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to ...